Health Products

M-Eslon (morphine sulfate) ER capsules: One lot recalled as some bottles labelled as M-Eslon 30 mg may contain 60 mg capsules, which may pose an overdose risk

· Published by Health Canada · Official notice

Details

Alert type: Public advisory
Category: Health products - Drugs
Product: M-Eslon (morphine sulfate) bottles labelled to contain 30 mg extended-release capsules may contain 60 mg extended-release capsules
Issue: Health products - Product safety
What to do: Check your M-Eslon (morphine sulfate) medication bottle or package. If your prescription is for 30 mg capsules and the bottle contains 60 mg capsules, or if you are unsure, do not take these capsules and return them to your pharmacy. If you or someone you are caring for is experiencing an overdose (symptoms are described below), call 911 immediately and seek immediate medical attention
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Images

Products

ProductDINLot numberExpiry date
M-Eslon (morphine sulfate) extended release capsules – bottles from the manufacturer are labelled as 30 mg020199494388504/2026

Issue

Ethypharm Inc. is recalling one lot of M-Eslon (morphine sulfate) extended release (ER) capsules because some bottles labelled as M-Eslon 30 mg ER may contain 60 mg capsules. This issue could lead to patients receiving a 60 mg dose instead of their prescribed 30 mg dose, which could result in an overdose and pose serious health risks.

M-Eslon is a prescription opioid drug used by adults for long-term pain management when pain is severe enough to require daily, around-the-clock painkillers and other treatment options are not able to treat the pain.

The 60 mg capsule has "60" and "M-ESLON" printed on it. The capsule has an opaque orange cap and a clear bottom.

The 30 mg capsule has "30" and "M-ESLON" printed on it. The capsule has an opaque pink cap and a clear bottom.

Taking too much morphine or suddenly increasing the dose could potentially lead to an overdose, which can be life-threatening. Symptoms of morphine overdose may include: confusion, dizziness, drowsiness, difficulties waking up, small (pinpoint) pupils, slow heartbeat, slow and difficult breathing, cold and clammy skin, fainting, seizure, coma and death.

Health Canada is monitoring the company's recall and investigation, including its implementation of corrective and preventive actions to stop this issue from reoccurring. The Department will inform the public if any new health risks are identified.

Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime